Intervention

Stereotactic ablative radiotherapy

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions10

Lead sponsors shown5

Clinical trials

5 shown

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative RadiotherapyNCT05808790 · 2024-01-01

NOT_YET_RECRUITING

Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular TachycardiaNCT05696522 · 2023-01-12

Targeted Radiotherapy for Recurrent Prostate CancerNCT05067660 · 2022-01-01

HDR Brachytherapy vs SABR in Early-intermediate Prostate CancerNCT04870567 · 2018-04-01

SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)NCT01953055 · 2013-11-01

Common conditions

Biochemical Relapse Free Survival1 Colorectal Cancer Metastatic1 Complications Rates (Erectile Dysfunction, GI, GU Complications)1 Heart Failure1 Lung Metastases1 Prostate Cancer1 Prostate Cancer Recurrence After Radical Prostatectomy1 Radiotherapy; Complications1 Structural Heart Abnormality1 Ventricular Tachycardia1

Leading sponsors

Amsterdam UMC, location VUmc1 Barts & The London NHS Trust1 N.N. Petrov National Medical Research Center of Oncology1 Sunnybrook Health Sciences Centre1 Tampere University Hospital1

Trial status mix

UNKNOWN3

COMPLETED1

NOT_YET_RECRUITING1

Phase mix

NA4

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.